The Cancer Attention Gap

THE RESEARCH QUESTION

Where does employer attention to cancer benefits fall short of the value leaders see in specialist expertise?

A study of the gap between employers' belief in early cancer expertise and how cancer-related benefit decisions are made.

Selected published findings

• 94% of surveyed leaders believed early expert intervention improves outcomes and reduces costs.
• 6% reported using external oncology specialists for high-cost cancer decisions.

Source: AccessHope + Lantern’s published report.

How the study was conducted

Published by AccessHope and Lantern. The public landing page identifies HR and benefits leaders as the audience; consult the full study for its sample and detailed methods.

The findings concern leaders' views and reported practices, not a clinical trial or proof of patient outcomes. No unverified sample size is supplied here.

What makes this Data as Marketing

A clear, research-backed benefits conversation that helps a healthcare brand make an important issue visible to its buyers.

This is an example of research becoming a public marketing asset, not a claim of measured revenue or lead-generation lift.